Skip to content

The correlation between drinking behavior and the dose of propofol in patients undergoing painless gastrointestinal endoscopy

The correlation between drinking behavior and the dose of propofol in patients undergoing painless gastrointestinal endoscopy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073694
Enrollment
Unknown
Registered
2023-07-19
Start date
2023-07-20
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with painless gastrointestinal endoscopy

Interventions

Excessive drinking group(hazardous and harmful drinkers):NA
non-excessive drinking group(no hazardous drinkers):NA

Sponsors

Department of Anesthesiology, Air Force Medical Center, Beijing, China.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) Age 25-55 years old; (2) ASA1-2; (3) No obvious abnormal liver and kidney function; (4) Sign the informed consent; (5) Audio-visual communication without barrier; (6) History of social drinking.

Exclusion criteria

Exclusion criteria: (1) Nervous system diseases such as Acute stroke, Alzheimer's disease, history of neurosurgery, and Parkinson; (2) Preoperative organ dysfunction; (3) Allergic to propofol; (4) Long-term use of sedatives, antidepressants, etc; (5) Difficult airway such as sleep apnea syndrome; (6) Patients or family refused; (7) BMI>30 or BMI<18.5 kg/m2.

Design outcomes

Primary

MeasureTime frame
target concentration of propofol;Awakening time;

Secondary

MeasureTime frame
Blood pressure;Time of gastrointestinal endoscopy;Total anesthesia time;Heart rate;End tidal CO2;

Countries

China

Contacts

Public ContactTianzhu Tao

Department of Anesthesiology, Air Force Medical Center, Beijing, China.

ttz887@126.com+86 185 1166 4103

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026